Barclays lowered the firm’s price target on Fresenius Medical (FMS) to EUR 40.50 from EUR 42.50 and keeps an Equal Weight rating on the shares.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on FMS:
- Fresenius Medical Care Announces AGM and New Capital Structure
- Fresenius Medical Care Completes Bond Tender Offer with Increased Acceptance
- Fresenius Medical Care AG Announces Strategic Debt Management Initiative
- Fresenius Medical Care Secures €1.1 Billion Through Bond Issuance
- Fresenius Medical Care’s Earnings Call Highlights Growth and Challenges
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue